Publications by authors named "Peter Dunnill"

Claim this Profile
N
New approaches to confronting an imminent influenza pandemic.
David S Fedson, Peter Dunnill

Perm J· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the value of autologous and allogeneic cells for regenerative medicine.
Chris Mason, Peter Dunnill

Regen Med· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantities of cells used for regenerative medicine and some implications for clinicians and bioprocessors.
Chris Mason, Peter Dunnill

Regen Med· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The need for a regen industry voice.
Chris Mason, Peter Dunnill

Regen Med· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The crucial linkage required between regenerative medicine bioprocessors and clinicians.
Chris Mason, Peter Dunnill

Regen Med· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The strong financial case for regenerative medicine and the regen industry.
Chris Mason, Peter Dunnill

Regen Med· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary: From scarcity to abundance: pandemic vaccines and other agents for "have not" countries.
David S Fedson, Peter Dunnill

J Public Health Policy· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A brief definition of regenerative medicine.
Chris Mason, Peter Dunnill

Regen Med· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons for the nascent regenerative medicine industry from the biotech sector.
Chris Mason, Peter Dunnill

Regen Med· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational regenerative medicine research: essential to discovery and outcome.
Chris Mason, Peter Dunnill

Regen Med· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads.
Julia F Markusen, Christopher Mason, Dearbhla A Hull, Martin A Town, Alethea B Tabor, Peter Dunnill

Tissue Eng· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic.
Mike Hoare, M Susana Levy, Daniel G Bracewell, Steven D Doig, Simyee Kong, Peter Dunnill

Biotechnol Prog· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A DNA flu vaccine in practice.
Peter Dunnill

Nat Biotechnol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Separation characteristics of liquid nematode cultures and the design of recovery operations.
John M Young, Peter Dunnill, Jeremy D Pearce

Biotechnol Prog· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis